#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study on Upadacitinib for Pain Management in Patients with Psoriatic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on Tofacitinib for Achieving Remission in Early Psoriatic Arthritis Patients Without Prior DMARD Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium

  • Study on Guselkumab for Treating Active Psoriatic Arthritis in Patients with Inadequate Response to One Prior Anti-TNF Agent

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Hungary Poland Spain

  • Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Denmark Germany Hungary Italy +5

  • Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Estonia Germany Italy Poland Slovakia +1

  • Study to Predict Tofacitinib Effectiveness in Psoriatic Arthritis Patients Using Tofacitinib, Methotrexate, and Folic Acid

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Not Used Anti-TNF Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Germany Poland Spain

  • Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Hungary Italy +2

  • Study on Deucravacitinib and Apremilast for Patients with Active Psoriatic Arthritis New to Biologic Treatments or Previously on TNFα Inhibitors

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Germany Hungary Poland Spain

  • Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments

    Not recruiting

    3 1
    Investigated Drugs:
    Bulgaria Czechia Finland France Hungary Ireland +4